SY-003

N/A

Report date: 2026/02/06 20:01:23
NME

Base Information

Drug NameSY-003
Drug Alias NameSY-003
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPolo like kinase inhibitorsGTPase Ras inhibitorsPI3-kinase class I inhibitors
TargetsPolo like kinaseGTPase RasPI3-kinase class I
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesYabao Pharmaceutical Group Co LtdUniversity Of South Australia
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesYabao Pharmaceutical Group Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A